ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VNDA Vanda Pharmaceuticals Inc

4.99
-0.02 (-0.40%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vanda Pharmaceuticals Inc NASDAQ:VNDA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.40% 4.99 4.50 5.40 5.08 4.87 5.00 1,384,022 05:00:08

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

31/01/2024 9:30pm

PR Newswire (US)


Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Vanda Pharmaceuticals Charts.

Conference Call and Webcast to Follow

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2023 on Wednesday, February 7, 2024, after the market closes.  

Vanda Logo (PRNewsfoto/Vanda Pharmaceuticals Inc.)

Vanda will host a conference call at 4:30 PM ET on Wednesday, February 7, 2024, during which management will discuss the fourth quarter and full year 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 8053170.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, February 7, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, February 14, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8053170.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2023-financial-results-on-february-7-2024-302049731.html

SOURCE Vanda Pharmaceuticals Inc.

Copyright 2024 PR Newswire

1 Year Vanda Pharmaceuticals Chart

1 Year Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart

Your Recent History